Eliminate Barriers To Cancer Research With Clinical Ink ePRO

Integrating electronic patient-reported outcomes (ePROs) helps clinicians understand symptoms, concerns, and a more thorough reporting of adverse events than is captured by traditional methods, which encourages increased patient retention in a market rapidly moving towards direct data capture.

Clinical ink’s holistic ePRO solutions offer mutual benefits for patients, sites, sponsors, and CROs in capturing and monitoring the patient experience. Empowering patients in cancer treatments, while enabling insights and data reviews, contribute to better clinical efficacy resulting in new therapies and enhanced drug development for the future.

Discover ways to remove burdens and barriers inherent in clinical trial participation and deliver a more patient-centric experience with Clinical ink’s ePRO.